PART ONE
General Cytology
32. George TI, Wrede JE, Bangs CD, et al.
Low-grade B-cell lymphomas with
plasmacytic differentiation lack PAX5
gene rearrangements.
J Mol Diagn
2005;7(3):346-351.
33. Poppe B, De Paepe P, Michaux L, et al.
PAX5/IGH rearrangement is a recurrent
finding in a subset of aggressive B-NHL
with complex chromosomal rearrange-
ments.
Genes Chromosomes Cancer
2005;44(2):218-223.
34. Akasaka H, Akasaka T, Kurata M, et al.
Molecular anatomy of BCL6 transloca-
tions revealed by long-distance polymer-
ase chain reaction-based assays.
Cancer
Res
2000;60(9):2335-2341.
35. Lossos IS. Molecular pathogenesis of dif-
fuse large B-cell lymphoma.
J Clin Oncol
2005;23(26):6351-6357.
36. Lossos IS, Morgensztern D. Prognos-
tic biomarkers in diffuse large B-cell
lymphoma.
J Clin Oncol
2006;24(6):995-
1007.
37. Alizadeh AA, Eisen MB, Davis RE, et
al. Distinct types of diffuse large B-cell
lymphoma identified by gene expression
profiling.
Nature
2000;403(6769):503-511.
38. Ohno H. Pathogenetic and clinical impli-
cations of non-immunoglobulin; BCL6
translocations in B-cell non-Hodgkin's
lymphoma.
J Clin Exp Hematop
2006;
46(2):43-53.
39. Li Z, Van Calcar S, Qu C, et al. A global
transcriptional regulatory role for c-Myc
in Burkitt's lymphoma cells.
Proc Natl
Acad Sci USA
2003;100(14):8164-8169.
40. Garcia JL, Hernandez JM, Gutiérrez NC,
et al. Abnormalities on 1q and 7q are
associated with poor outcome in sporadic
Burkitt's lymphoma. A cytogenetic and
comparative genomic hybridization
study.
Leukemia
2003;17(10):2016-2024.
41. Kutock JL, Aster JC. Molecular biology
of anaplastic lymphoma kinase-positive
anaplastic large-cell lymphoma.
J Clin
Oncol
2002;20(17):3691-3702.
42. ten Berge RL, Oudejans JJ, Ossenkopele
GJ, et al. ALK-negative systemic anaplastic
large cell lymphoma: differential diagnos-
tic and prognostic aspects—a review.
J Pathol
2003;200(1):4-15.
43. Helman LJ, Meltzer P. Mechanisms of
sarcoma development.
Nat Rev Cancer
2003;3(9):685-694.
44. Lazar A, Abruzzo LV, Pollock RE,
et al. Molecular diagnosis of sarcomas:
chromosomal translocations in sarcomas.
Arch Pathol Lab Med
2006;130(8):
1199-1207.
45. Barr FG, Zhang PJ. The impact of genetics
on sarcoma diagnosis: an evolving
science.
Clin Cancer Res
2006;12(18):5256-5257.
46. Argani P, Antonescu CR, Illei PB, et
al. Primary renal neoplasms with the
ASPL-TFE3 gene fusion of alveolar soft
part sarcoma: a distinctive tumor entity
previously included among renal cell
carcinomas of children and adolescents.
Am J Pathol
2001;159(1):179-192.
47. Parham, DM, Ellison DA. Rhabdomyosa-
rcomas in adults and children: an update.
Arch Pathol Lab Med
2006;130(10):1454-
1465.
48. Tsuda M, Davis IJ, Argani P, et al. TFE3
fusions activate MET signaling by
transcriptional up-regulation, defining
another class of tumors as candidates for
therapeutic MET inhibition.
Cancer Res
2007;67(3):919-929.
49. Greaves MF, Wiemels J. Origins of
chromosome translocations in child-
hood leukaemia.
Nat Rev Cancer
2003;3(9):639-649.
50. Vandesompele J, Baudis M, De Preter K,
et al. Unequivocal delineation of clinico-
genetic subgroups and development
of a new model for improved outcome
prediction in neuroblastoma.
J Clin Oncol
2005;23(10):2280-2299.
51. Pierotti MA. Chromosomal rearrange-
ments in thyroid carcinomas: a recom-
bination or death dilemma.
Cancer Lett
2001;166(1):1-7.
52. Santoro M, Mellilo RM, Fusco A.
RET/PTC activation in papillary thyroid
carcinoma: European Journal of Endo-
crinology Prize Lecture.
Eur J Endocrinol
2006;155(5):645-653.
53. Kondo T, Ezzat S, Asa SL. Pathogenetic
mechanisms in thyroid follicular-cell
neoplasia.
Nat Rev Cancer
2006;6(4):
292-306.
54. Dass DK. Value and limitations of fine-
needle aspiration cytology in diagnosis
and classification of lymphomas: A
review.
Diagn Cytopathol
1999;21(4):
240-249.
55. Soderlund V, Tani E, Skoog L, et al. Diag-
nosis of skeletal lymphoma and myeloma
by radiology and fine needle aspiration
cytology.
Cytopathology
2001;12(3):
157-167.
56. Dey P, Amir T, Al Jassar A, et al. Com-
bined applications of fine needle
aspiration cytology and flow cytometric
immunophenotyping for diagnosis and
classification of non Hodgkin lym-
phoma.
Cytojournal
2006;3:24.
57. Kaleem Z, White G, Vollmer RT. Critical
analysis and diagnostic usefulness of lim-
ited immunophenotyping of B-cell non-
Hodgkin lymphomas by flow cytometry.
Am J Clin Pathol
2001;115(1):136-142.
58. Gong JZ, Lagoo AS, Peters D, et al.
Value of CD23 determination by flow
cytometry in differentiating mantle cell
lymphoma from chronic lymphocytic
leukemia/small lymphocytic lymphoma.
Am J Clin Pathol
2001;116(6):893-897.
59. Barry TS, Jaffe ES, Kingma DW, et al.
CD5+ follicular lymphoma: a clinico-
pathologic study of three cases.
Am J Clin
Pathol
2002;118(4):589-598.
60. Safley AM, Buckley PJ, Creager AJ, et al.
The value of fluorescence in situ hybridi-
zation and polymerase chain reaction
in the diagnosis of B-cell non-Hodgkin
lymphoma by fine-needle aspiration.
Arch Pathol Lab Med
2004;128(12):
1395-1403.
61. Kocjan G. Best Practice No 185. Cyto-
logical and molecular diagnosis of lym-
phoma.
J Clin Pathol
2005;58(6):561-567.
62. Dey P. Role of ancillary techniques in
diagnosing and subclassifying non-
Hodgkin's lymphomas on fine needle
aspiration cytology.
Cytopathology
2006;17(5):275-287.
63. Liu K, Dodd LG, Powers JA, et al. Detec-
tion of trisomy 12 by fluorescence in situ
hybridization on archival cytopathologic
material in chronic lymphocytic leuke-
mia/small lymphocytic lymphoma.
Acta
Cytol
2000;44(3):368-374.
64. Bentz JS, Rowe LR, Anderson SR, et al.
Rapid detection of the t(11;14) trans-
location in mantle cell lymphoma by
interphase fluorescence in situ hybridiza-
tion on archival cytopathologic material.
Cancer
2004;102(2):124-131.
65. Kishimoto K, Kitamura T, Fujita K, et al.
Cytologic differential diagnosis of fol-
licular lymphoma grades 1 and 2 from
reactive follicular hyperplasia: cyto-
logic features of fine-needle aspiration
smears with Pap stain and fluorescence
in situ hybridization analysis to detect
t(14;18)(q32;q21) chromosomal translo-
cation.
Diagn Cytopathol
2006;34(1):
11-17.
66. Richmond J, Bryant R, Trotman W,
et al. FISH detection of t(14;18) in
follicular lymphoma on Papanicolaou-
stained archival cytology slides.
Cancer
2006;108(3):198-204.
67. Jiang F, Katz RL. Use of interphase fluo-
rescence in situ hybridization as a power-
ful diagnostic tool in cytology.
Diagn Mol
Pathol
2002;11(1):47-57.
68. Wolff DJ, Bagg A, Cooley LD, et al. Guid-
ance for fluorescence in situ hybridiza-
tion testing in hematologic disorders.
J Mol Diagn
2007;9(2):134-143.
69. Frater JL, Tsiftsakis Ek, His ED, et al. Use
of novel t(11;14) and t(14;18) dual-
fusion fluorescence in situ hybridization
probes in the differential diagnosis of
lymphomas of small lymphocytes.
Diagn
Mol Pathol
2001;10(4):214-222.
70. Alkan S, Lehman C, Sarago C, et al.
Polymerase chain reaction detection of
immunoglobulin gene rearrangement
and bcl-2 translocation in archival glass
slides of cytologic material.
Diagn Mol
Pathol
1995;4(1):25-31.
71. Gong Y, Caraway N, Gu J, et al. Evalu-
ation of interphase fluorescence in situ
hybridization for the t(14;18)(q32;q21)
translocation in the diagnosis of follicular
lymphoma on fine-needle aspirates:
a comparison with flow cytometry
immunophenotyping.
Cancer
2003;99(6):385-393.
72. Buno I, Nava P, Alvarez-Doval A, et al.
Lymphoma associated chromosomal
abnormalities can easily be detected
by FISH on tissue imprints. An under-
used diagnostic alternative.
J Clin Pathol
2005;58(6):629-633.
73. Belaud-Rotureau MA, Parrens M, Carrere
N, et al. Interphase fluorescence in situ
hybridization is more sensitive than
BIOMED-2 polymerase chain reac-
tion protocol in detecting IGH-BCL2
rearrangement in both fixed and frozen
lymph node with follicular lymphoma.
Human Pathol
2007;38(2):365-372.
74. Belaud-Rotureau MA, Parrens M, Dubus
P, et al. A comparative analysis of FISH,
RT-PCR, PCR, and immunohistochemis-
try for the diagnosis of mantle cell lym-
phomas.
Mod Pathol
2002;15(5):517-525.
44
previous page 50 ComprehensiveCytopathology 1104p 2008 read online next page 52 ComprehensiveCytopathology 1104p 2008 read online Home Toggle text on/off